ACADIAN ASSET MANAGEMENT LLC

Position in NKTX — Nkarta, Inc.

CIK 916542 Boston, MA

Position in NKTX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$3,850,350

+$1,192,223 QoQ

Shares Held

1,360,548

+8.0% QoQ

Ownership

1.90%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#12

of 136 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $731,256,203 across 167 Biotechnology names. NKTX ranks #26 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,664,999	$188,744,286
2	REGN	Regeneron Pharmaceuticals, Inc.	157,440	$98,170,137
3	IMCR	Immunocore Holdings plc	1,209,894	$38,414,134
4	RIGL	Rigel Pharmaceuticals Inc	591,686	$23,146,756
5	EXEL	Exelixis, Inc.	421,444	$22,930,768
6	VRTX	Vertex Pharmaceuticals Inc / Ma	42,122	$20,923,261
7	TBPH	Theravance Biopharma, Inc.	1,174,910	$19,973,470
8	PRTA	Prothena Corp Public Ltd Co	2,010,645	$19,684,214

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,850,350	1,360,548	+8.0%	Shares	Defined	2026-08-13
2026-03-31	$2,658,127	1,259,776	+82.0%	Shares	Defined	2026-05-13
2025-12-31	$1,280,360	692,087	+35.5%	Shares	Defined	2026-02-10
2025-09-30	$1,057,140	510,696	+7.3%	Shares	Defined	2025-11-13
2025-06-30	$789,972	475,887	-24.4%	Shares	Defined	2025-08-07
2025-03-31	$1,158,055	629,378	-25.9%	Shares	Defined	2025-05-21
2024-12-31	$2,116,004	849,801	+96.4%	Shares	Defined	2025-02-11
2024-09-30	$1,956,179	432,783	+42.6%	Shares	Defined	2024-11-12
2024-06-30	$1,793,454	303,461	+11164.3%	Shares	Defined	2024-08-06
2024-03-31	$29,122	2,694	-97.0%	Shares	Defined	2024-05-10
2023-12-31	$598,415	90,669	+40.5%	Shares	Defined	2024-02-13
2023-09-30	$89,723	64,549	+94.6%	Shares	Defined	2023-11-13
2023-03-31	$117,739	33,166	—	Shares	Defined	2023-05-11
No filing history on record for this holder in this stock.